X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (45) 45
male (30) 30
female (24) 24
adult (22) 22
index medicus (22) 22
infectious diseases (21) 21
hiv (17) 17
middle aged (17) 17
aids (15) 15
immunology (15) 15
hiv infections - drug therapy (14) 14
viral load (11) 11
microbiology (10) 10
hepatitis c (9) 9
hiv infection (9) 9
virology (9) 9
care and treatment (8) 8
hiv infections - virology (8) 8
hiv-1 - drug effects (8) 8
human immunodeficiency virus--hiv (8) 8
human-immunodeficiency-virus (8) 8
drug therapy, combination (7) 7
hiv infections - epidemiology (7) 7
hiv-1 - genetics (7) 7
infections (7) 7
public, environmental & occupational health (7) 7
aged (6) 6
aids/hiv (6) 6
antiviral agents (6) 6
epidemics (6) 6
life sciences (6) 6
mortality (6) 6
pharmacology & pharmacy (6) 6
prevalence (6) 6
anti-hiv agents - therapeutic use (5) 5
drug administration schedule (5) 5
drug therapy (5) 5
genotype (5) 5
hepatitis c - epidemiology (5) 5
hiv infections - complications (5) 5
hiv patients (5) 5
hiv/aids (5) 5
lopinavir (5) 5
medicine, general & internal (5) 5
resistance (5) 5
risk factors (5) 5
ritonavir - therapeutic use (5) 5
rna, viral - blood (5) 5
salvage therapy (5) 5
acquired immune deficiency syndrome--aids (4) 4
analysis (4) 4
animals (4) 4
antiretroviral therapy (4) 4
antiretroviral therapy, highly active (4) 4
developing countries (4) 4
disease (4) 4
france (4) 4
hemorrhagic fever, ebola - epidemiology (4) 4
highly active antiretroviral therapy (4) 4
hiv infections - prevention & control (4) 4
hiv infections - therapy (4) 4
hiv protease inhibitors - therapeutic use (4) 4
human immunodeficiency virus (4) 4
indinavir (4) 4
lopinavir/ritonavir (4) 4
prognosis (4) 4
protease inhibitors (4) 4
public health (4) 4
santé publique et épidémiologie (4) 4
sulfonamides - therapeutic use (4) 4
therapy (4) 4
treatment outcome (4) 4
tuberculosis (4) 4
adolescent (3) 3
aids-related opportunistic infections - microbiology (3) 3
antiretroviral drugs (3) 3
brief reports (3) 3
carbamates - therapeutic use (3) 3
coinfection (3) 3
combination (3) 3
complications (3) 3
disease progression (3) 3
epidemiology (3) 3
hepatitis (3) 3
hepatitis b virus (3) 3
hepatitis c - complications (3) 3
hiv infections (3) 3
hiv infections - blood (3) 3
hiv infections - diagnosis (3) 3
hiv protease - genetics (3) 3
inject drugs (3) 3
internal medicine (3) 3
medical research (3) 3
people (3) 3
prevention (3) 3
protease inhibitor therapy (3) 3
pyrimidinones - therapeutic use (3) 3
research article (3) 3
ritonavir - administration & dosage (3) 3
sulfonamides - administration & dosage (3) 3
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Infectious Diseases, ISSN 1058-4838, 4/2001, Volume 32, Issue 8, pp. 1207 - 1214
Journal Article
Journal of the International AIDS Society, ISSN 1758-2652, 01/2015, Volume 18, Issue 1, pp. 19888 - n/a
Journal Article
Journal of Public Health Policy, ISSN 0197-5897, 11/2012, Volume 33, Issue 4, pp. 430 - 438
The HIV/AIDS pandemic has generated international solidarity, particularly with sub-Saharan Africa. The mainly vertical approach to this challenge has,... 
Commentary | Hepatitis | Health policy | Neglected diseases | Funding | Health care industry | Diabetes | Hepatitis B virus | Epidemiology | Publishing industry | Public health | HIV/AIDS | viral hepatitis | resource limited settings | noncommunicable diseases | public health policy | Africa | COUNTRIES | VIRUS | non-communicable diseases | PREVENTION | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | HEALTH CARE SCIENCES & SERVICES | NONCOMMUNICABLE DISEASES | SYSTEMS | HEALTH POLICY & SERVICES | BURDEN | HIV Infections - prevention & control | Delivery of Health Care - organization & administration | Global Health | HIV Infections - economics | HIV Infections - epidemiology | Hepatitis, Viral, Human - therapy | Humans | Health Priorities | Hepatitis, Viral, Human - epidemiology | Neglected Diseases - prevention & control | Neglected Diseases - therapy | Hepatitis, Viral, Human - prevention & control | Delivery of Health Care - economics | Neglected Diseases - economics | Respiratory Tract Diseases - epidemiology | Diabetes Mellitus - epidemiology | Cardiovascular Diseases - epidemiology | HIV Infections - therapy | Neglected Diseases - epidemiology | Africa South of the Sahara - epidemiology | Neoplasms - epidemiology | Public health administration | Analysis | Health care rationing | Health care | Liver cancer | Medical research | Immunization | Acquired immune deficiency syndrome--AIDS | Human immunodeficiency virus--HIV | Mortality | Developing countries--LDCs
Journal Article
AIDS, ISSN 0269-9370, 11/2015, Volume 29, Issue 17, pp. 2347 - 2351
Objective: Liberia's health system has been severely struck by the 2014 Ebola epidemic. We aimed to assess the potential effect of this epidemic on the care of... 
Liberia | HIV | Ebola | epidemic | INFECTIOUS DISEASES | VIROLOGY | IMMUNOLOGY | Health Services Administration - standards | Epidemics | Health Services Administration - trends | HIV Infections - diagnosis | Humans | HIV Infections - therapy | Adult | Female | Male | Liberia - epidemiology | Hemorrhagic Fever, Ebola - epidemiology | Life Sciences
Journal Article
Lung Cancer, ISSN 0169-5002, 2008, Volume 65, Issue 3, pp. 345 - 350
Abstract Objective To evaluate the impact of highly active antiretroviral therapy (HAART) on survival in HIV infected patients with non-small-cell lung cancer... 
Hematology, Oncology and Palliative Medicine | Pulmonary/Respiratory | Adenocarcinoma | Highly active antiretroviral therapy | Non Small Cell Lung Cancer | Lung Cancer | Human Immunodeficiency Virus Infection | performans Status | DRUG-THERAPY | CYCLOPHOSPHAMIDE | AIDS | PREDNISONE CHEMOTHERAPY | HUMAN-IMMUNODEFICIENCY-VIRUS | PACLITAXEL | KAPOSIS-SARCOMA | ONCOLOGY | ERA | RESPIRATORY SYSTEM | VINCRISTINE | NON-HODGKINS-LYMPHOMA | Lung Neoplasms - drug therapy | Prognosis | Lung Neoplasms - mortality | Humans | Middle Aged | Lung Neoplasms - pathology | Male | Carcinoma, Non-Small-Cell Lung - diagnosis | HIV-1 - physiology | HIV Infections - diagnosis | Female | HIV Infections - mortality | Carcinoma, Non-Small-Cell Lung - pathology | Virus Replication - drug effects | Carcinoma, Non-Small-Cell Lung - mortality | Disease Progression | Lung Neoplasms - complications | Antiretroviral Therapy, Highly Active | Carcinoma, Non-Small-Cell Lung - complications | HIV Infections - complications | Survival Analysis | HIV Infections - drug therapy | Carcinoma, Non-Small-Cell Lung - drug therapy | Lung Neoplasms - diagnosis | Neoplasm Staging | Virus diseases | Antiviral agents | Care and treatment | Cancer patients | Patient outcomes | HIV patients | HIV (Viruses) | Lung cancer, Non-small cell | HIV infection | Cancer | HIV Infections | HIV-1 | Carcinoma, Non-Small-Cell Lung | Lung Neoplasms | Life Sciences | Virus Replication | Santé publique et épidémiologie
Journal Article
Journal Article
Journal Article
Journal of Hepatology, ISSN 0168-8278, 2008, Volume 50, Issue 2, pp. 432 - 434
Multiple hepatitis co-infections are frequent in HIV-infected patients, often resulting in severe liver diseases that are difficult to treat. We report here... 
Gastroenterology and Hepatology | AIDS | Co-infection | Pegylated-interferon | Hepatitis C | Hepatitis delta | Hepatitis B | B-VIRUS | EFFICACY | CHRONIC HEPATITIS-DELTA | SUPPRESSION | GASTROENTEROLOGY & HEPATOLOGY | PCR
Journal Article
Medicine, ISSN 0025-7974, 01/2000, Volume 79, Issue 1, pp. 47 - 56
Journal Article
18.